Literature DB >> 10599440

Interferon alpha for the treatment of superficial bladder cancer.

J Naitoh1, J Franklin, M A O'Donnell, A S Belldegrun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10599440     DOI： 10.1007/978-1-4615-4737-2_29

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  2 in total

1.  Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity.

Authors:  Y Luo; X Chen; R Han; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 2.  Immune escape mechanisms and immunotherapy of urothelial bladder cancer.

Authors:  Zhao Yang; Yinyan Xu; Ying Bi; Nan Zhang; Haifeng Wang; Tianying Xing; Suhang Bai; Zongyi Shen; Faiza Naz; Zichen Zhang; Liqi Yin; Mengran Shi; Luyao Wang; Lei Wang; Shihui Wang; Lida Xu; Xin Su; Song Wu; Changyuan Yu
Journal:  J Clin Transl Res       Date:  2021-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.